Evaluation of publicly available data indicates SMARCA4 mRNA levels are significantly higher compared to SMARCA2 mRNA levels in NB cell lines (depmap.org) as well as in NB patients’ tumors (r2.amc.nl) (Appendix Fig. S1C). This evidence concerns the gene SMARCA4 and neuroblastoma.